Apomorphine, adverse reactionsApomorphine, pharmacokineticsApomorphine, therapeutic useDrug-delivery-systemsParkinson's-disease, treatmentTrial-result-clinicalVarious-toxicities, drug-inducedVectura
"Our findings mark TMEM16F as a possible new target for the development of effective treatments for Parkinson's disease. If, by inhibiting TMEM16F, we can stop or reduce the secretion of defective α-synuclein from brain cells, we may be able to slow down or even halt the spread of the ...
Author(s): Jessica AL Hutter-Saunders 1 , Rodney Lee Mosley 1 , Howard E Gendelman [**] 2 Keywords : immunization; immunotherapy; neurodegeneration; Parkinson's disease; regulatory T cells; T cells Next to Alzheimer's disease (AD), Parkinson's disease (PD) is the second most common neuro...
Aclinical trial has shown for the first time that zonisamide, an kanticonvulsant, was safe and effective as an adjunctive treatment for patients with Parkinson disease (PD). The results from the study were published in the Jan. 2 Neurology (2007/68:45-60).Investigators in Japan, led ...
CHA University Bundang Medical Center (CBMC) said on Monday that its researchers proved the safety and effectiveness of dopamine neural precursor cells derived from fetal mesenchymal stem cells transplanted into patients with Parkinson's disease "for the
(2009) Effective control of catatonia in Parkinson's disease by electroconvulsive therapy: a case report. European Journal of Neurology 16: E6-E6.Kamigaichi R, Kubo S, Ishikawa K, Yokoyama K, Ogaki K, Usui C, Hatta K, Arai H, Mochizuki H, Hattori N (2009) Effective control of ...
QUESTION: Does Tai Chi improve postural control in patients with Parkinson's disease? DESIGN: Randomised, controlled trial and blinded outcome assessment. SETTING: University clinic in USA. PARTICIPANTS: Individuals with Parkinson's disease (Hoehn and Yahr Stage 1-4) between the age of 40 and 85...
Wegovy to Be Covered by US Medicare for Heart Disease Patients Accepting a Valuable Gift From a Patient: It's Tempting, but Is It Right? General Neurology Needs Recruits and Respect Recommended Reading Diseases & Conditions Parkinson Disease Diseases & Conditions Parkinson Disease and LRRK2 ...
Medical treatment of dystonia. Neurotherapeutics. 2014;11(1):139-153. doi:10.1007/s13311-013-0248-2 Bonuccelli U, Del Dotto P, Lucetti C, Ceravolo R, Gambaccini G, Rossi G. Zinc and manganese in the pathogenesis of Parkinson's disease and parkinsonism. Neurotoxicology. 2000;21(3):353-...
possibility of using mRNA technology as a treatment for Alzheimer’s disease and Huntington's disease [44]. As another material used to target the brain to treat many neurological disorders, polyplex micelles are prepared using poly(N′-(N-(2-aminoethyl)-2-aminoethyl) aspartamide and DET (...